124th MAINE LEGISLATURE | ||||||
LD 1672 | LR 2249(04) | |||||
An Act To Require a Pharmacist To Provide Prior Notification to and Obtain Consent from the Prescribing Physician before Changing from One Formulation or Manufacturer of an Antiepileptic Drug to Another | ||||||
Fiscal Note for Senate Amendment " " to Committee Amendment "A" | ||||||
Sponsor: Sen. Marrache of Kennebec | ||||||
Fiscal Note Required: Yes | ||||||
Fiscal Note | ||||||
Minor cost increase - General Fund Minor cost increase - Other Special Revenue Funds |
||||||
Fiscal Detail and Notes | ||||||
Additional costs to the Board of Pharmacy within the Office of Licensing and Registration, Department of Professional and Financial Regulation, the Board of Licensure in Medicine, affiliated with the Department of Professional and Financial Regulation, the Office of MaineCare Services in the Department of Health and Human Services and the Governor's Office of Health Policy and Finance to conduct the required study and submit the required report can be absorbed within existing budgeted resources. |